Reasons to think biotech will roar again — and reasons to worry it won't - STAT

Reasons to think biotech will roar again — and reasons to worry it won't - STAT

Reasons to think biotech will roar — or not 

October has been brutal for biotech stocks, marked by consistent volatility and adding up to a downward slope. The industry is now negative for the year, and everyone’s upset.

And so we decided to dive into the silver linings that suggest biotech will be fine and explore the festering wounds that might mark it for further anguish. We’ve got some things to like — science is still good, and money is still flowing into the sector — and some things to fear, like the paucity of big M&A and the fact that history points to a worsening trend.

Read more.